News
TRAIN lecture
VPM will give a lecture for the TRAIN academy on 7th November 2019 at TWINCORE with the title „ Methods for successful project management - achieving project goals faster and more securer."
World Health Summit 2019
VPM will take part in the World Health Summit from 27-29 October in Berlin.
Press release on the 12th International VPM Days 2019
On 12 and 13 September, the 12th International VPM Days took place at TWINCORE in Hannover. More than 20 international speakers and almost 100 visitors accepted the invitation of Vakzine Projekt Management GmbH (VPM). Read more!
BIO Europe 2019
VPM will take part in the BIO Europe from 11-13 November in Hamburg. It is Europe's largest partnering conference for global biotechnology industry and international forum for business development between pharmaceutical, financial and biotechnology companies.
TRAIN Kick-Off
VPM as partner of the TRAIN academy wants to invite people to come to the TRAIN kick-off meeting at TWINCORE on 17 October 2019.
VPM is part of a consulting Team for the European Commission within Horizon 2020 on Tuberculosis Vaccines
VPM will take part in the TB Meeting "Maintaining European scientific excellence and global leadership in TB Vaccine R&D" on 8 October 2019 in Brussels.
priMe: Investigator Meeting
Serum Institute of India Pvt. Ltd. and Vakzine Projekt Management GmbH are delighted to announce the Investigator Meeting of the priMe trial, taking place from 27-28th of November 2019 at the Ramada Resort Hotel, Dar es Salaam, Tanzania.
FORUM intensive course: Quality Specialist in Clinical Research
VPM will be speaker for the FORUM intensive course "Quality Specialist in Clinical Research" from 21.10. - 24.10.2019 in Heidelberg.
FORUM seminar: Quality Management in small Organizational Units
VPM will be speaker of the FORUM Seminar "Quality Management in Small Organizational Units" from 23.09. - 24.09.2019 in Mannheim.
Cruzivax Kick-Off Meeting
VPM will take part in the Cruzivax Kick-off Meeting, organized by Helmholtz Centre for Infection Research (HZI) from 26 - 27 June 2019 in Frankfurt. Aim of the Cruzivax project is to develop a vaccine against the Chagas disease which is funded by Horizon 2020.